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Abstract 
Clinical Decision Support Systems help the delivery of care by supplementing generic 
clinical guidelines with decision support. This is achieved by encompassing patient-
specific recommendations that support the implementation of the computer-interpretable 
guidelines (CIGs). CIG implementation involves understanding the risks and outcomes of 
a treatment, which may show diversifications between patients with multiple diseases and 
those without. The objective of this study is to present a state-of-the-art approach for CIG-
based treatment personalisation routes and stages for patients with multiple diseases. 
Introduction 
Treatment of several chronic diseases is a challenging task, due to their complex 
management involving continuous monitoring, evaluation and amendment of a care plan. 
This is exacerbated by multiple conditions, which can be at odds with each other in terms 
of medication compatibility between diagnostics, treatment plans and amount of available 
medical information. Since the population is aging, there is a vast number of people 
suffering from multimorbidities that can be defined as the co-existence of two or more 
chronic diseases in one individual 1. In order to contribute to the well-being, quality of life 
and life-expectancy of a patient, recommendations should not cause any serious conflicts 
between medications of different diseases (i.e., drug-drug or drug-patient interactions), 
adverse effects on other diseases while treating the index disease (i.e. drug-disease 
interactions) or be inconsistent and/or unnecessary. To deal with these complex patients 
and their associate disease risks, treatment personalization is required.  
Clinical Decision Support Systems (CDSSs) help to customize care plans for each patient. 
In the case of multimorbid and comorbid patients this requires conciliation of the activities 
recommended by various single-disease clinical practice guidelines (CPGs), which are 
mainly paper-based clinical protocols and provide evidence-based clinical 
recommendations to caregivers regarding diagnosis, therapy or treatment plans on treating 
a particular disease. CDSSs can also help to highlight and offer early warning to caregivers 
on potential issues that may not be seen in time, due to the complexities and the 
‘decentralised’ approach of morbidities. CPGs have no adaptability to dynamic states in 
patient health conditions; particularly, in the presence of multi-morbidities this is an 
important issue, as CPGs are static and mostly designed for the treatment of a single 
disease. Thus, they are not able to address the needs of patients with complex concurrent 
diseases2 that can be linked with decreasing life expectancy, quality of life and increasing 
risk of adverse drug events. 
CPGs can be formalised into a digital form, called computer-interpretable guidelines 
(CIGs), in order to increase their flexibility, minimise errors and generalise the use of 
guidelines across organisations.  For instance; Arden Syntax3, GLIF4, and Asbru5 are some 
of the well-known formalisations for representing CIGs. Studies have shown that the 
adoption of CIG-based CDSS can reduce clinical errors, improve the caregiver 
performance and patient outcomes, as well as reduce the inefficient patient attendances 
(returning patients) and hospital costs6,7. In this study, we summarise the state-of-the art of 
the literature and proposed a CIG-based framework on the treatment personalisation routes 
of patients with multiple diseases, under a clinical decision support context.  
Methods 
We systematically review the literature on activity based views of how CIGs are used in 
CDSSs to personalize treatments. We consider papers that have been published between 
2000 and 2017 on scientific journals by querying Science Direct, Web of Science, and 
PubMed.  The search terms covered “computer interpretable guidelines”, “clinical 
guidelines”, “computer-assisted decision making”, “clinical decision support systems”, 
“patient-centred care”, “care pathway” AND “computer based guidelines”, “workflow” 
AND “computerised guidelines”, and “guideline interactions”. In addition, we conduct a 
grey literature search. We then derive a systematic workflow on personalisation treatment 
routes for multi-morbid patients, through the use of CIGs. 
Results 
To demonstrate how treatments are customized (i.e. personalized care routes) using CDSS, 
and how CIGs are integrated into a care-flow, we introduce a short description of a patient 
treatment journey as follows:  if patients would like to be treated by a caregiver, initially 
they should be registered to an integrated electronic healthcare record (EHR) system of one 
of the treating medical centres. Such system can record patients’ visits in terms of episodes 
of care, e.g. reason for encounter, lab tests, x-ray results, treatments. Integrated EHR 
systems can be connected with a CDSS. Hence, the caregiver can use the CDSS to get 
information about the patient, and make an initial assessment regarding the patients’ 
disease(s). Afterwards, the caregiver may provide her assessments to the system as an 
input, as well as including other clinical information via the graphical interface of the 
CDSS. This information is then linked with the CIGs. By this integration, disease can be 
detected and the treatment of a patient can be started, based on the solicited decision 
support output of the CDSS and the patient-caregiver shared decision making that 
caregiver establishes the treatment target, schedule and supplies information on patient 
preferences/requests, in return patient aims to obtain information on his disease and has a 
voice over the decision making. This paper has resulted in the identification of the typical 
use of CIGs in healthcare and presents a summary of the main stages (as patient-medical 
centre, CIG-CDSS and patient-caregiver encounters) that CIGs are (in) directly involved 
in, one would expect to find when using CDSS for morbidities.  
Discussion 
CDSSs support the implementation of CIGs targeting the improvement of healthcare 
actors’ performances on clinical decision-making, quality of care and patient safety. The 
reviewed publications show that the key fields of work are still open for further 
investigation: CIG interactions and medical knowledge, merging and execution of co-
existing CIGs for multi-disease treatments, guideline interaction analysis: new methods, 
techniques and algorithms etc., timing constraints, and patient empowerment in CDSSs.   
Conclusion 
This paper summarises the findings of an extensive review of the literature on the key 
components of CDSSs for the treatment of morbidities and also proposes a framework of 
integrating CIGs into the delivery of care. Care customisation has been widely investigated 
in the literature8,9 with different perspectives, approaches and solution methods.  As far as 
we are concerned, we are the first that consider the implementation steps of CIG-driven 
treatment personalisation pathways, including guideline, temporal factor, and patient-
caregiver interactions. Our proposed framework can be useful for researchers and/or 
healthcare actors to understand how treatments of patients with multiple-diseases can be 
personalised. In addition, it provides an understanding of how clinical recommendation 
mechanisms work in practice, and how the adoption of CIG-based CDSS and patient-
centred care can improve the caregiver performances, patient outcomes and healthcare 
processes. 
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